A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...
It promised better power, reliability, and fuel economy. Sadly, though, virtually none of those promises were delivered.
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Marilyn Ong Marilyn Ong is an editor covering kitchen gear. She has ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Superformance has turned the dream of owning a 1960s-style race car into something you can actually order, register, and ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Jan. 9, 2026 Scientists in South Korea have discovered a way to make all-solid-state batteries safer and more powerful using inexpensive materials. Instead of adding costly metals, they redesigned the ...